The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases.
The addition of Cigna's 13.3 millionUSmembers gives the company more than 115 million covered lives for the test.
The conference was relatively light on new mass spec launches, with many vendors focusing instead on more targeted applications of existing technology.
The effort has provided a comprehensive view of the toxin proteins involved in the sting of these dangerous jellyfish, which is now being used to identify targets for inhibitory drugs.
The partners will screen for molecules that could revive metabolic activity in heart tissue damaged by cardiovascular disease or failure.
In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.
A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.
As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.